16701CLOU064P12301OpenA randomized, double-blind, placebo-controlled Phase III
study to evaluate the efficacy and safety of remibrutinib in
patients with secondary progressive multiple sclerosisIndustrialAdultTreatmentIIIOtherBarry, BrianMedStar Health and GUMC; Medstar Washington Hospital CenterMedStar Neuroscience & Rehab Research Network2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">© 2026 Advarra, Inc.</a>